Abstract:Intracerebral hemorrhage (ICH) is the most common subtype of hemorrhagic stroke. After ICH, blood components extravasate from vessels into the brain, activating immune cells and causing them to release a series of inflammatory mediators. Immune cells, together with inflammatory mediators, lead to neuroinflammation in the perihematomal region and the whole brain, and neuroinflammation is closely related to secondary brain injury as well as functional recovery of the brain. Despite recent progress in understanding the pathophysiology of ICH, there is still no effective treatment for this disease. MicroRNAs (miRNAs) are non-coding RNAs 17-25 nucleotides in length that are generated naturally in the human body. They bind complementarily to messenger RNAs and suppress translation, thus regulating gene expression at the post-transcriptional level. They have been found to regulate the pathophysiological process of ICH, particularly the neuroinflammatory cascade. Multiple preclinical studies have shown that manipulating the expression and activity of miRNAs can modulate immune cell activities, influence neuroinflammatory responses, and ultimately affect neurological functions after ICH. This implicates the potentially crucial roles of miRNAs in post-ICH neuroinflammation and indicates the possibility of applying miRNA-based therapeutics for this disease. Thus, this review aims to address the pathophysiological roles and molecular underpinnings of miRNAs in the regulation of neuroinflammation after ICH. With a more sophisticated understanding of ICH and miRNAs, it is possible to translate these findings into new pharmacological therapies for ICH.

Intracerebral Hemorrhage in Translational Research

Remote Diffusion-Weighted Imaging Lesions in Intracerebral Hemorrhage: Characteristics, Mechanisms, Outcomes, and Therapeutic Implications

Research progress on animal model and potential therapeutic strategy in intracere-bral hemo rrhage

Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage.

Treatment of Intracerebral Hemorrhage: Current Approaches and Future Directions

Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): From mechanisms to translation

Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions

Iron and Intracerebral Hemorrhage: From Mechanism to Translation

MicroRNAs Modulate Neuroinflammation after Intracerebral Hemorrhage: Prospects for New Therapy.

Intracerebral haemorrhage — mechanisms, diagnosis and prospects for treatment and prevention

Pathophysiological Mechanisms and Potential Therapeutic Targets in Intracerebral Hemorrhage

Intracerebral hemorrhage: an update on diagnosis and treatment

Predictors of Mortality and Recurrent Stroke Within Five Years of Intracerebral Hemorrhage.

Blood-Based Biomarkers in Intracerebral Hemorrhage

Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update

Research Progress in Understanding the Relationship Between Heme Oxygenase-1 and Intracerebral Hemorrhage

Surgical timing of intracerebral hemorrhage

Advances in computed tomography-based prognostic methods for intracerebral hemorrhage

Evolving Therapeutic Landscape of Intracerebral Hemorrhage: Emerging Cutting-Edge Advancements in Surgical Robots, Regenerative Medicine, and Neurorehabilitation Techniques

An Update on Inflammation in the Acute Phase of Intracerebral Hemorrhage

Mechanism and application of immune interventions in intracerebral haemorrhage